FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4220736221> ?p ?o ?g. }

• W4220736221 endingPage "5216" @default.
• W4220736221 startingPage "5207" @default.
• W4220736221 abstract "The prognostic impact of tumor-infiltrating lymphocytes (TILs) on outcomes and treatment efficacy for patients with melanoma in the contemporary era remains poorly characterized.Consecutive patients who underwent wide excision and sentinel lymph node biopsy for cutaneous melanoma 1 mm thick or thicker at a single institution were identified (2006-2019). The patients were stratified based on primary tumor TIL status as brisk (bTILs), non-brisk (nbTILs), or absent (aTILs). Associations between patient factors and outcomes were analyzed using multivariable analysis.Of the 1017 patients evaluated, 846 (83.2 %) had primary TILs [nbTILs (n = 759, 89.7 %) and bTILs (n = 87, 10.3 %)]. In the multivariable analysis, the patients with any type of TILs had higher rates of regression [odds ratio (OR), 1.86; p = 0.016], lower rates of acral lentiginous histology (OR, 0.22; p < 0.001), and lower rates of SLN positivity (OR, 0.64; p = 0.042) than those without TILs. The multivariable analysis found no association between disease-specific survival and bTILs [hazard ratio (HR), 1.04; p = 0.927] or nbTILs (HR, 0.89; p = 0.683). An association was found between bTILs and recurrence-free survival (RFS) advantage [bTILs (HR 0.46; p = 0.047), nbTILs (HR 0.71; p = 0.088)], with 5-year RFS rates of 84 % for bTILs, 71.8 % for nbTILs, and 68.4 % for aTILs (p = 0.044). For the 114 immune checkpoint blockade (ICB)-naïve patients who experienced a recurrence treated with ICB therapy, no association was observed between progression-free survival and bTILs (HR, 0.64; p = 0.482) or nbTILs (HR, 0.58; p = 0.176).The prognostic significance of primary TILs in the contemporary melanoma era appears complex. Further studies characterizing the phenotype of TILs and their association with regional metastasis and responsiveness to ICB therapy are warranted." @default.
• W4220736221 created "2022-04-03" @default.
• W4220736221 creator A5003970032 @default.
• W4220736221 creator A5004480921 @default.
• W4220736221 creator A5010640368 @default.
• W4220736221 creator A5021517578 @default.
• W4220736221 creator A5033111279 @default.
• W4220736221 creator A5035929126 @default.
• W4220736221 creator A5047225945 @default.
• W4220736221 creator A5048615638 @default.
• W4220736221 creator A5061056221 @default.
• W4220736221 creator A5089745812 @default.
• W4220736221 date "2022-03-17" @default.
• W4220736221 modified "2023-10-07" @default.
• W4220736221 title "Prognostic Significance of Primary Tumor-Infiltrating Lymphocytes in a Contemporary Melanoma Cohort" @default.
• W4220736221 cites W1780052723 @default.
• W4220736221 cites W1965306336 @default.
• W4220736221 cites W1971211622 @default.
• W4220736221 cites W2018187312 @default.
• W4220736221 cites W2039123767 @default.
• W4220736221 cites W2072487610 @default.
• W4220736221 cites W2078197336 @default.
• W4220736221 cites W2083574998 @default.
• W4220736221 cites W2118342755 @default.
• W4220736221 cites W2133415133 @default.
• W4220736221 cites W2150770343 @default.
• W4220736221 cites W2159040226 @default.
• W4220736221 cites W2160253118 @default.
• W4220736221 cites W2226616534 @default.
• W4220736221 cites W2237180596 @default.
• W4220736221 cites W2266995761 @default.
• W4220736221 cites W2292383635 @default.
• W4220736221 cites W2294207258 @default.
• W4220736221 cites W230810425 @default.
• W4220736221 cites W2419413911 @default.
• W4220736221 cites W2460712522 @default.
• W4220736221 cites W2482999389 @default.
• W4220736221 cites W2592515605 @default.
• W4220736221 cites W2604905128 @default.
• W4220736221 cites W2766512176 @default.
• W4220736221 cites W2790011096 @default.
• W4220736221 cites W2910849865 @default.
• W4220736221 cites W2930324748 @default.
• W4220736221 cites W2951296513 @default.
• W4220736221 cites W2997147165 @default.
• W4220736221 cites W3045360487 @default.
• W4220736221 cites W3122132002 @default.
• W4220736221 cites W3125299889 @default.
• W4220736221 cites W3178115416 @default.
• W4220736221 cites W3200816639 @default.
• W4220736221 cites W3201408301 @default.
• W4220736221 doi "https://doi.org/10.1245/s10434-022-11478-4" @default.
• W4220736221 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35301610" @default.
• W4220736221 hasPublicationYear "2022" @default.
• W4220736221 type Work @default.
• W4220736221 citedByCount "7" @default.
• W4220736221 countsByYear W42207362212022 @default.
• W4220736221 countsByYear W42207362212023 @default.
• W4220736221 crossrefType "journal-article" @default.
• W4220736221 hasAuthorship W4220736221A5003970032 @default.
• W4220736221 hasAuthorship W4220736221A5004480921 @default.
• W4220736221 hasAuthorship W4220736221A5010640368 @default.
• W4220736221 hasAuthorship W4220736221A5021517578 @default.
• W4220736221 hasAuthorship W4220736221A5033111279 @default.
• W4220736221 hasAuthorship W4220736221A5035929126 @default.
• W4220736221 hasAuthorship W4220736221A5047225945 @default.
• W4220736221 hasAuthorship W4220736221A5048615638 @default.
• W4220736221 hasAuthorship W4220736221A5061056221 @default.
• W4220736221 hasAuthorship W4220736221A5089745812 @default.
• W4220736221 hasBestOaLocation W42207362212 @default.
• W4220736221 hasConcept C121608353 @default.
• W4220736221 hasConcept C126322002 @default.
• W4220736221 hasConcept C143998085 @default.
• W4220736221 hasConcept C156957248 @default.
• W4220736221 hasConcept C207103383 @default.
• W4220736221 hasConcept C2775934546 @default.
• W4220736221 hasConcept C2777658100 @default.
• W4220736221 hasConcept C2777701055 @default.
• W4220736221 hasConcept C2778326572 @default.
• W4220736221 hasConcept C2780140570 @default.
• W4220736221 hasConcept C2780589465 @default.
• W4220736221 hasConcept C44249647 @default.
• W4220736221 hasConcept C502942594 @default.
• W4220736221 hasConcept C50382708 @default.
• W4220736221 hasConcept C71924100 @default.
• W4220736221 hasConcept C72563966 @default.
• W4220736221 hasConcept C90924648 @default.
• W4220736221 hasConceptScore W4220736221C121608353 @default.
• W4220736221 hasConceptScore W4220736221C126322002 @default.
• W4220736221 hasConceptScore W4220736221C143998085 @default.
• W4220736221 hasConceptScore W4220736221C156957248 @default.
• W4220736221 hasConceptScore W4220736221C207103383 @default.
• W4220736221 hasConceptScore W4220736221C2775934546 @default.
• W4220736221 hasConceptScore W4220736221C2777658100 @default.
• W4220736221 hasConceptScore W4220736221C2777701055 @default.
• W4220736221 hasConceptScore W4220736221C2778326572 @default.
• W4220736221 hasConceptScore W4220736221C2780140570 @default.
• W4220736221 hasConceptScore W4220736221C2780589465 @default.

• next